Health Care vs Healthcare: The AP Style Debate and Prior Authorization Frustrations

On April 27, 2026, the Associated Press (AP) Stylebook officially updated its guidelines to prefer the closed compound “healthcare” over the two-word “health care” in most contexts. The change, announced via the AP Stylebook’s social media channels, has reignited a long-standing debate among journalists, medical professionals, and policy experts about language precision in reporting on the U.S. Medical system. While the shift may appear minor, it arrives amid broader scrutiny of healthcare practices—particularly prior authorization—a process that insurers use to determine coverage for treatments, medications, and procedures.

AP Stylebook’s Grammar Decision Reflects Evolving Industry Language

The AP’s decision to adopt “healthcare” as the default term aligns with growing usage in policy documents, corporate communications, and medical literature. Paula Froke, lead editor of the AP Stylebook, acknowledged in a 2026 interview that the debate over “health care” versus “healthcare” had persisted for years, with frequent inquiries from journalists seeking clarity. The AP’s move formalizes a trend already observed in federal agencies, advocacy groups, and major insurers, which increasingly favor the single-word form to describe the system of medical services and insurance.

Critics of the change argue that the two-word form—”health care”—better distinguishes between the act of providing medical services (“care”) and the broader industry (“health”). However, the AP’s updated guidance notes that “healthcare” can be used as both a noun and an adjective, simplifying usage in headlines and tight writing. The stylebook retains exceptions for specific phrases, such as “health care provider” or “health care system,” where the two-word form remains preferred for clarity.

The timing of the AP’s decision coincides with heightened public frustration over administrative barriers in healthcare, particularly prior authorization—a process that has drawn bipartisan criticism for delaying patient access to necessary treatments. While the style change is largely symbolic, it underscores how language shapes perceptions of an industry under pressure to reform.

Prior Authorization: A System Under Fire

Prior authorization requires healthcare providers to obtain approval from insurers before delivering certain treatments, medications, or procedures. Insurers argue the process prevents unnecessary or overly expensive care, but physicians, hospitals, and patients have long criticized it as bureaucratic, time-consuming, and dangerous. A 2026 interview with Archelle Georgiou, a former executive at UnitedHealthcare, revealed the internal tensions driving the practice. Georgiou, who helped reduce prior authorization requirements at the insurer in the early 2010s, described the system as one where “the denial is the outcome”—a process designed to limit costs, not improve care.

The consequences of prior authorization delays are well-documented. A 2025 commentary in The New England Journal of Medicine highlighted cases where patients faced life-threatening complications while waiting for approvals, including a child with new-onset Type 1 diabetes denied generic insulin and an infant in respiratory distress blocked from hospital admission due to an unmet prior authorization requirement. Physicians report spending an average of 16 hours per week navigating prior authorization requests, time that detracts from direct patient care.

The administrative burden extends beyond physicians. A 2025 RAND Corporation analysis found that prior authorization relies on outdated methods, such as faxed forms and peer-to-peer phone calls between specialists and insurance employees who may lack clinical expertise. If a fax fails to transmit or a call is missed, the request is automatically denied. These inefficiencies contribute to physician burnout and erode trust in the healthcare system, according to Jihad Abdelgadir and Gabriela Plasencia, the authors of the RAND commentary.

Insurers Pledge Reforms, But Skepticism Remains

In June 2025, major U.S. Insurers—including UnitedHealthcare, Aetna (owned by CVS Health), and others—announced voluntary commitments to reform prior authorization. The pledges included reducing the number of treatments requiring authorization, standardizing electronic submissions, ensuring continuity of care during insurance transitions, and expanding real-time approvals by 2027. Insurers also promised to create dashboards to improve transparency and communication among providers, patients, and payers.

However, the commitments lack enforcement mechanisms, leaving critics doubtful about their impact. Dr. Mehmet Oz, who oversees the Centers for Medicare and Medicaid Services (CMS) as of 2026, acknowledged the skepticism during a news conference in June 2025. “There’s violence in the streets over this,” Oz said, referencing public outrage following the fatal shooting of UnitedHealthcare CEO Brian Thompson in December 2024, which many linked to frustrations over insurance practices. “Americans are upset about it,” Oz added, suggesting that insurers were motivated to act but stopping short of endorsing the voluntary nature of the reforms.

The insurers’ promises echo previous efforts that yielded little change. A 2023 CMS rule aimed to modernize prior authorization by requiring public insurers to implement electronic systems by 2026, but adoption has been slow. Meanwhile, private insurers continue to expand the scope of prior authorization, particularly for high-cost treatments like specialty drugs and advanced imaging.

Balancing Cost Control and Patient Access

Proponents of prior authorization argue that it prevents overuse of medical services and reduces unnecessary spending. A 2023 analysis in The New England Journal of Medicine noted that simplifying the process could increase healthcare utilization, potentially raising costs for patients and insurers. However, the authors—Michael Anne Kyle and Zirui Song of Harvard Medical School—acknowledged that prior authorization disproportionately affects vulnerable populations, including those with chronic illnesses or limited access to care.

The debate over prior authorization reflects broader tensions in the U.S. Healthcare system, where cost control often clashes with patient access. While insurers frame the practice as a necessary safeguard, providers and patients experience it as a barrier to timely, effective care. The AP’s stylebook update—shifting to “healthcare”—may seem like a small change, but it arrives at a moment when the industry’s administrative practices are under unprecedented scrutiny.

What Comes Next?

For now, the insurers’ voluntary reforms remain unenforceable, leaving their impact uncertain. Advocacy groups and medical societies continue to push for legislative solutions, including federal mandates to streamline prior authorization and cap processing times. Meanwhile, the AP’s language shift signals a broader cultural shift in how the industry is discussed—one that may influence public perception as the debate over healthcare reform intensifies.

As Georgiou noted in her interview, the real test of prior authorization reform will be whether insurers prioritize patient outcomes over cost savings. For now, the system remains a flashpoint in the ongoing struggle to balance efficiency, affordability, and access in American healthcare.